Advertisement

Fluoroscopy-free AF ablation using transesophageal echocardiography and electroanatomical mapping technology

Abstract

Purpose

Guidelines recommend that radiation exposure during AF catheter ablation procedures should be ‘as low as reasonably achievable’ (ALARA), particularly since many patients may have multiple procedures. Consequently, avoiding radiation exposure altogether must, if safe to do so, be the ultimate goal. The primary objective was to determine the feasibility and efficacy of fluoroscopy-free AF ablation compared to the fluoroscopy-assisted procedure.

Methods

Patients underwent AF ablation using commercially available technology with no routine pre-procedural imaging. The use of non-fluoroscopic imaging/mapping technologies permitted us to initially reduce x-ray exposure before eliminating its use altogether. This evolution of our practice proceeded in two stages: a 9-month period of optimising our fluoroscopy-free ablation protocol followed by a 9-month period during which we set out to complete the whole procedure routinely without fluoroscopy. We describe the protocol developed and report salient endpoints, such as complications, procedure times, patient experience, and procedural success rates.

Results

During the study period, fluoroscopy-free AF ablation was attempted in 69 patients: 24 in the 9-month ‘development phase’ and 45 in the ‘implementation phase’. During the development phase, 13 of 24 patients (54%) were treated without the use of fluoroscopy. In the implementation phase, 45 patients underwent AF ablation of which 42 (93.3%) were fluoroscopy-free. A detailed description is given of the three cases in which fluoroscopy had to be used despite an intention not to.

Conclusions

Fluoroscopy-free complex ablation procedures for the treatment of atrial fibrillation are safe and feasible in most patients.

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

Fig. 1
Fig. 2

References

  1. 1.

    Lickfett L, Mahesh M, Vasamreddy C, Bradley D, Jayam V, Eldadah Z, et al. Radiation exposure during catheter ablation of atrial fibrillation. Circulation. 2004;110(19):3003–10. https://doi.org/10.1161/01.cir.0000146952.49223.11.

  2. 2.

    Scaglione M, Ebrille E, Caponi D, Siboldi A, Bertero G, Di Donna P, et al. Zero-fluoroscopy ablation of accessory pathways in children and adolescents: CARTO3 electroanatomic mapping combined with RF and cryoenergy. Pacing Clin Electrophysiol. 2015;38(6):675–81. https://doi.org/10.1111/pace.12619.

  3. 3.

    Clark J, Bockoven JR, Lane J, Patel CR, Smith G. Use of three-dimensional catheter guidance and trans-esophageal echocardiography to eliminate fluoroscopy in catheter ablation of left-sided accessory pathways. Pacing Clin Electrophysiol. 2008;31(3):283–9. https://doi.org/10.1111/j.1540-8159.2008.00987.x.

  4. 4.

    Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14(4):528–606. https://doi.org/10.1093/europace/eus027.

  5. 5.

    Limacher MC, Douglas PS, Germano G, Laskey WK, Lindsay BD, McKetty MH, et al. ACC expert consensus document. Radiation safety in the practice of cardiology. American College of Cardiology. J Am Coll Cardiol. 1998;31(4):892–913.

  6. 6.

    The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP. 2007;37(2–4):1–332. https://doi.org/10.1016/j.icrp.2007.10.003.

  7. 7.

    Natale A, Reddy VY, Monir G, Wilber DJ, Lindsay BD, McElderry HT, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol. 2014;64(7):647–56. https://doi.org/10.1016/j.jacc.2014.04.072.

  8. 8.

    Perisinakis K, Damilakis J, Theocharopoulos N, Manios E, Vardas P, Gourtsoyiannis N. Accurate assessment of patient effective radiation dose and associated detriment risk from radiofrequency catheter ablation procedures. Circulation. 2001;104(1):58–62.

  9. 9.

    Bulava A, Hanis J, Eisenberger M. Catheter ablation of atrial fibrillation using zero-fluoroscopy technique: a randomized trial. Pacing Clin Electrophysiol. 2015;38(7):797–806. https://doi.org/10.1111/pace.12634.

  10. 10.

    Lee G, Hunter RJ, Lovell MJ, Finlay M, Ullah W, Baker V, et al. Use of a contact force-sensing ablation catheter with advanced catheter location significantly reduces fluoroscopy time and radiation dose in catheter ablation of atrial fibrillation. Europace. 2016;18(2):211–8. https://doi.org/10.1093/europace/euv186.

  11. 11.

    Earley MJ, Showkathali R, Alzetani M, Kistler PM, Gupta D, Abrams DJ, et al. Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J. 2006;27(10):1223–9. https://doi.org/10.1093/eurheartj/ehi834.

  12. 12.

    Kistler PM, Rajappan K, Harris S, Earley MJ, Richmond L, Sporton SC, et al. The impact of image integration on catheter ablation of atrial fibrillation using electroanatomic mapping: a prospective randomized study. Eur Heart J. 2008;29(24):3029–36. https://doi.org/10.1093/eurheartj/ehn453.

  13. 13.

    Caponi D, Corleto A, Scaglione M, Blandino A, Biasco L, Cristoforetti Y, et al. Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome? a randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace. 2010;12(8):1098–104. https://doi.org/10.1093/europace/euq107.

  14. 14.

    Rolf S, John S, Gaspar T, Dinov B, Kircher S, Huo Y, et al. Catheter ablation of atrial fibrillation supported by novel nonfluoroscopic 4D navigation technology. Heart Rhythm. 2013;10(9):1293–300. https://doi.org/10.1016/j.hrthm.2013.05.008.

  15. 15.

    Kuhne M, Knecht S, Muhl A, Reichlin T, Pavlovic N, Kessel-Schaefer A, et al. Fluoroscopy-free pulmonary vein isolation in patients with atrial fibrillation and a patent foramen ovale using solely an electroanatomic mapping system. PLoS One. 2016;11(1):e0148059. https://doi.org/10.1371/journal.pone.0148059.

  16. 16.

    Raju H, Whitaker J, Taylor C, Wright M. Electroanatomic mapping and transoesophageal echocardiography for near zero fluoroscopy during complex left atrial ablation. Heart Lung Circ. 2016;25(7):652–60. https://doi.org/10.1016/j.hlc.2016.01.018.

  17. 17.

    Razminia M, Manankil MF, Eryazici PL, Arrieta-Garcia C, Wang T, D'Silva OJ, et al. Nonfluoroscopic catheter ablation of cardiac arrhythmias in adults: feasibility, safety, and efficacy. J Cardiovasc Electrophysiol. 2012;23(10):1078–86. https://doi.org/10.1111/j.1540-8167.2012.02344.x.

  18. 18.

    Razminia M, Willoughby MC, Demo H, Keshmiri H, Wang T, D'Silva OJ, et al. Fluoroless catheter ablation of cardiac arrhythmias: a 5-year experience. Pacing Clin Electrophysiol. 2017. https://doi.org/10.1111/pace.13038.

  19. 19.

    Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Europace. 2012;14(10):1385–413. https://doi.org/10.1093/europace/eus305.

  20. 20.

    Della Bella P, Fassini G, Cireddu M, Riva S, Carbucicchio C, Giraldi F, et al. Image integration-guided catheter ablation of atrial fibrillation: a prospective randomized study. J Cardiovasc Electrophysiol. 2009;20(3):258–65. https://doi.org/10.1111/j.1540-8167.2008.01311.x.

  21. 21.

    Macias R, Uribe I, Tercedor L, Jimenez-Jaimez J, Barrio T, Alvarez M. A zero-fluoroscopy approach to cavotricuspid isthmus catheter ablation: comparative analysis of two electroanatomical mapping systems. Pacing Clin Electrophysiol. 2014;37(8):1029–37. https://doi.org/10.1111/pace.12376.

  22. 22.

    Fernandez-Gomez JM, Morina-Vazquez P, Morales Edel R, Venegas-Gamero J, Barba-Pichardo R, Carranza MH. Exclusion of fluoroscopy use in catheter ablation procedures: six years of experience at a single center. J Cardiovasc Electrophysiol. 2014;25(6):638–44. https://doi.org/10.1111/jce.12385.

  23. 23.

    Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17–20.

  24. 24.

    Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD, et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke prevention: assessment of risk in a community. Mayo Clin Proc. 1999;74(9):862–9.

  25. 25.

    Pavlovic N, Reichlin T, Kuhne M, Knecht S, Osswald S, Sticherling C. Fluoroscopy-free recrossing of the interatrial septum during left atrial ablation procedures. J Interv Card Electrophysiol. 2014;41(3):261–6. https://doi.org/10.1007/s10840-014-9952-5.

  26. 26.

    Lehrmann H, Schneider J, Jadidi AS, Park CI, Schiebeling-Romer J, Allgeier J, et al. Transseptal access for left atrial ablation: the catheter-probing techniques are not without risk. J Cardiovasc Electrophysiol. 2014;25(5):479–84. https://doi.org/10.1111/jce.12356.

  27. 27.

    Sporton SC, Earley MJ, Nathan AW, Schilling RJ. Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol. 2004;15(3):310–5. https://doi.org/10.1111/j.1540-8167.2004.03356.x.

  28. 28.

    Knecht S, Sticherling C, Reichlin T, Pavlovic N, Muhl A, Schaer B, et al. Effective reduction of fluoroscopy duration by using an advanced electroanatomic-mapping system and a standardized procedural protocol for ablation of atrial fibrillation: ‘the unleaded study’. Europace. 2015;17(11):1694–9. https://doi.org/10.1093/europace/euv006.

  29. 29.

    Scaglione M, Biasco L, Caponi D, Anselmino M, Negro A, Di Donna P, et al. Visualization of multiple catheters with electroanatomical mapping reduces X-ray exposure during atrial fibrillation ablation. Europace. 2011;13(7):955–62. https://doi.org/10.1093/europace/eur062.

  30. 30.

    Reddy VY, Morales G, Ahmed H, Neuzil P, Dukkipati S, Kim S, et al. Catheter ablation of atrial fibrillation without the use of fluoroscopy. Heart Rhythm. 2010;7(11):1644–53. https://doi.org/10.1016/j.hrthm.2010.07.011.

  31. 31.

    Ullah W, McLean A, Tayebjee MH, Gupta D, Ginks MR, Haywood GA, et al. Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data. Heart Rhythm. 2016;13(9):1761–7. https://doi.org/10.1016/j.hrthm.2016.05.011.

Download references

Acknowledgments

We are grateful to our colleagues helping to administer the audit, Senior Nurse Practitioner Claire Chitty, Office managers Cristina Thorne and Melanie Todd.

We want to thank the allied health professionals and nurses working in our catheter laboratories, supporting our ongoing quest to improve care for patients suffering atrial fibrillation.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

RS and BOB conceived the paper. DB collated and analysed the data. BOB drafted the manuscript. DB, RH, and RS critically revised the manuscript.

Correspondence to Benjamin O’Brien.

Ethics declarations

Conflict of interest

Richard Schilling has received research grants for Biosense Webster, Medtronic, St Jude Medical, Boston Scientific, Biotronik, Speaker fees for Biosense, Medtronic, Boeringher Ingleheim.

Ethical approval

This fluoro-free ablation protocol was developed to achieve best practice by following published ALARA guidance. Our analysis was performed retrospectively. For this type of study, formal consent is not required.

Additional information

Benjamin O’Brien, Damian C. Balmforth, Ross J. Hunter, and Richard J. Schilling are the authors who take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation.

Electronic supplementary material

(MP4 9954 kb).

(MP4 23,653 kb).

(MP4 17,095 kb).

ESM 1

(MP4 9954 kb).

ESM 2

(MP4 23,653 kb).

ESM 3

(MP4 17,095 kb).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

O’Brien, B., Balmforth, D.C., Hunter, R.J. et al. Fluoroscopy-free AF ablation using transesophageal echocardiography and electroanatomical mapping technology. J Interv Card Electrophysiol 50, 235–244 (2017) doi:10.1007/s10840-017-0288-9

Download citation

Keywords

  • Atrial fibrillation
  • Ablation
  • Fluoroscopy
  • Radiation
  • ALARA (as low as reasonably achievable)